Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk, Pfizer sweeten bid for Metsera

Digest more
 · 19h
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
A bidding war over U. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 billion battle with U.

Continue reading

 · 2d · on MSN
Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer
 · 16h · on MSN
Factbox-What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
Devdiscourse
2d

Legal Showdown: Pfizer and Novo Nordisk Clash Over Metsera in Fierce Obesity Drug Battle

Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...
12h

What is TrumpRx? Deal with Eli Lilly, Novo Nordisk, Medicare on weight loss drug coverage

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...
14hon MSN

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know. Sluggish growth for Novo Nordisk's GLP-1 drugs caused the company to again reduce its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms